Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventions

Not Applicable

Completed

• Conditions: Elective endoscopic oesophageal interventions; Surgery

• Registration Number: ISRCTN68599804
• Lead Sponsor: Academic Medical Centre (AMC) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-04-16
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Eligible patients for participation in this clinical trial are those planned to undergo elective endoscopic oesophagus intervention. The patients must comply with the following criteria in order to be eligible to participate in this clinical study:
1. Male and female, age range = 18 years without upper age limit
2. ASA classification I ? III
3. Written informed consent

Exclusion Criteria

1. Age range < 18 years
2. ASA classification IV and V
3. Allergic reaction to planned medication in the patients? medical history
4. Unregulated hypertension
5. Hypovolemia or hypotension (systolic blood pressure <80 or mean arterial pressure <50 mmHg)
6. Severe bradycardia (heart rate < 50/min) and / or related brady-dysrhythmias (e.g. advanced heart block)
7. Impaired ventricular function (left ventricular ejection fraction <30%)
8. Impaired renal function, GFR less than 15ml/min or undergoing hemodialysis
9. Impaired liver function
10. Substance abuse

Study & Design

• Study Type: Interventional
• Study Design: Not specified